|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NANOPHASE TECHNOLOGIES CORPORATION, 10-Q, 2000-08-14 |
Next: ENDOSONICS CORP, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 504,781
<SECURITIES> 18,785,372
<RECEIVABLES> 1,154,256
<ALLOWANCES> 86,450
<INVENTORY> 950,813
<CURRENT-ASSETS> 22,124,117
<PP&E> 4,253,520
<DEPRECIATION> 2,270,007
<TOTAL-ASSETS> 24,297,257
<CURRENT-LIABILITIES> 1,825,614
<BONDS> 0
0
0
<COMMON> 49,654,587
<OTHER-SE> (27,182,944)
<TOTAL-LIABILITY-AND-EQUITY> 24,297,257
<SALES> 1,488,007
<TOTAL-REVENUES> 1,724,257
<CGS> 2,123,985
<TOTAL-COSTS> 4,994,322
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (2,687,326)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,687,326)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,687,326)
<EPS-BASIC> (0.20)
<EPS-DILUTED> (0.20)
</TABLE>
|
|